Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
228 Leser
Artikel bewerten:
(1)

Avicenna.AI Secures CE Mark for Two Spine-Focused Medical Imaging AI Tools

EU certification granted for AI algorithms for vertebral compression fracture quantification and cervical spine fracture detection.

MARSEILLE, France, June 5, 2025 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received CE Mark certification for CINA-VCF Quantix, a new AI algorithm designed to detect and assess unsuspected vertebral compression fractures (VCFs) in patients undergoing CT scans for unrelated conditions. The company also secured CE Mark certification for CINA-CSpine, an AI tool designed to detect and triage cervical spine fractures from CT images.

The CE mark signifies that both products meet the stringent health and safety standards required by the European Union, enabling them to be deployed across the European Economic Area without additional regulatory barriers.

VCFs, often caused by bone deterioration due to osteoporosis, can lead to significant pain, deformity, and height loss. In the U.S. alone, approximately 750,000 adults suffer osteoporotic VCFs annually, but nearly two-thirds go undiagnosed, increasing the risk of further fractures and complications.

CINA-VCF Quantix is intended for patients aged 50 and older undergoing CT scans of the chest and/or abdomen for other conditions. The tool automatically labels vertebrae and calculates vertebral height loss ratios in the thoracic and lumbar spine. If a vertebral height loss ratio exceeds 20%-25%, indicating a moderate to severe VCF, CINA-VCF Quantix generates a passive notification, prompting radiologists to report early findings and supporting proactive patient care.

"Osteoporotic vertebral fractures can have a profound impact on patients' quality of life. The launch of CINA-VCF Quantix in Europe represents a major step forward in preventive care, empowering clinicians to intervene before minor fractures escalate," said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. "By encouraging the reporting of VCF presence and severity, CINA-VCF Quantix has the potential to make a real difference in long-term patient outcomes."

Cervical spine fractures, typically caused by trauma, involve breaks in one or more of the seven cervical vertebrae in the neck. If the spinal cord is affected, these fractures can cause neurological damage or paralysis. Early diagnosis and treatment are critical to improving outcomes and minimizing long-term complications.

CINA-CSpine automatically flags suspected acute cervical spine fractures, alerting radiologists through their existing systems for faster diagnosis and intervention.

"The launch of CINA-CSpine in the European market marks a significant step forward in trauma care. By reducing the time between scan and diagnosis, we're helping radiologists catch cervical spine fractures faster and more reliably - a crucial advance when every minute counts," said Di Grandi. "CINA-CSpine serves as a second pair of eyes, enhancing diagnostic confidence and ultimately improving patient outcomes across Europe."

All of Avicenna.AI's products are seamlessly integrated into radiologists' clinical workflow, automatically triggering and reporting algorithm results through the systems already used by radiologists. The company's product portfolio also includes AI tools for:

  • Intracranial hemorrhage (CINA-ICH)
  • Large vessel occlusion (CINA-LVO)
  • Aortic dissection (CINA-AD)
  • Pulmonary embolism (CINA-PE and CINA-iPE)
  • Vertical compression fractures (CINA-VCF)
  • And ASPECT Score for quantification of stroke severity (CINA-ASPECTS).

About Avicenna.AI
Founded in 2018, Avicenna.AI specializes in providing healthcare AI solutions that utilize deep learning to identify, detect, and quantify severe pathologies from CT medical images. Co-founded by Cyril Di Grandi, a successful entrepreneur who previously co-founded Olea Medical, and Dr. Peter Chang, an internationally recognized radiologist, and an expert in AI and deep learning, Avicenna.AI aims to accelerate therapeutic decision-making processes and enhance patient outcomes through its AI-based radiology solutions. For additional details, stay connected with us on social media and explore Avicenna.AI's website at www.avicenna.ai.

Cision View original content:https://www.prnewswire.co.uk/news-releases/avicennaai-secures-ce-mark-for-two-spine-focused-medical-imaging-ai-tools-302474190.html

© 2025 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.